Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

http://www.businessweek.com/news/2012-11-29/generic-lipitor-supply-adequate-as-ranbaxy-recalls-pills

Bloomberg News

Generic Lipitor Supply Adequate as Ranbaxy Recalls Pills

November 29, 2012

Ranbaxy Laboratories Ltd. (RBXY)’s recall and production halt of its version of the cholesterol pill Lipitor won’t create a supply shortage, U.S. regulators said.

Ranbaxy has stopped making the generic pills while it investigates how glass particles got into the product, the Food and Drug Administration said today in a statement. The company, based near New Delhi, announced Nov. 23 it had recalled the medicine. The FDA said it hasn’t received any reports of patients being harmed.

To contact the reporter on this story: Drew Armstrong in New York at darmstrong17@bloomberg.net;

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus